首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   81035篇
  免费   6191篇
  国内免费   259篇
耳鼻咽喉   932篇
儿科学   2145篇
妇产科学   1102篇
基础医学   10901篇
口腔科学   845篇
临床医学   8533篇
内科学   17416篇
皮肤病学   916篇
神经病学   7896篇
特种医学   3088篇
外科学   13154篇
综合类   927篇
一般理论   93篇
预防医学   6111篇
眼科学   1970篇
药学   5626篇
中国医学   95篇
肿瘤学   5735篇
  2023年   676篇
  2022年   1049篇
  2021年   2421篇
  2020年   1368篇
  2019年   2229篇
  2018年   2549篇
  2017年   1819篇
  2016年   1921篇
  2015年   2231篇
  2014年   3249篇
  2013年   4104篇
  2012年   6585篇
  2011年   6809篇
  2010年   3731篇
  2009年   3264篇
  2008年   5465篇
  2007年   5663篇
  2006年   5249篇
  2005年   5221篇
  2004年   4715篇
  2003年   4321篇
  2002年   3901篇
  2001年   657篇
  2000年   454篇
  1999年   608篇
  1998年   812篇
  1997年   601篇
  1996年   491篇
  1995年   440篇
  1994年   411篇
  1993年   406篇
  1992年   297篇
  1991年   251篇
  1990年   231篇
  1989年   202篇
  1988年   192篇
  1987年   170篇
  1986年   159篇
  1985年   175篇
  1984年   210篇
  1983年   174篇
  1982年   249篇
  1981年   243篇
  1980年   182篇
  1979年   114篇
  1978年   132篇
  1977年   114篇
  1976年   88篇
  1975年   74篇
  1974年   84篇
排序方式: 共有10000条查询结果,搜索用时 20 毫秒
1.
2.
3.
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal...  相似文献   
4.
5.
Abstract

Objective

Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies.  相似文献   
6.
7.
8.
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology  相似文献   
9.
Arthroscopic acromioclavicular joint excision is a commonly performed but technically demanding procedure. Incomplete excision can leave residual symptoms. We present a simple, reproducible technique ensuring satisfactory excision of the joint.  相似文献   
10.
Coronavirus disease 2019 (COVID-19) has resulted in many challenges in patient care, especially among high-risk populations such as heart transplant recipients. Patients with heart transplant experience a significantly higher mortality rate with COVID-19 infection, and management is based on extrapolation from clinical trials done on nontransplant patients and from clinical experience. Here we report 4 cases of patients with heart transplant who presented with COVID-19 infection in late 2020. Patients presented with symptoms similar to those seen in the general population. All 4 patients were admitted to the hospital, and they were all treated with dexamethasone. In addition, 2 patients received remdesivir. Immunosuppressive medications were adjusted to maintain adequate levels of immunosuppression but at the same time allow for an adequate immune response against the infection. All patients were discharged alive from the hospital. We then performed a literature review on studies that included heart transplant patients who developed the infection and developed suggestions for a standardized management approach, which we share in this article.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号